Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Carbone

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Cancer Gene Therapy|July 1, 1996
Increased immunogenicity of tumors bearing mutant p53 and P1A epitopes after transduction of B7-1 via recombinant adenovirusC T Lee, I F Ciernik, S Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Clinical significance of defective dendritic cell differentiation in cancerB Almand, J R Resser, B Lindman, et al.
Immunity|June 23, 2001
Regulation of mast cell survival by IgEK Asai, J Kitaura, Y Kawakami, et al.
International Journal of Cancer|September 17, 1996
Structural and functional analysis of beta2 microglobulin abnormalities in human lung and breast cancerH L Chen, D Gabrilovich, A Virmani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
A model for CD8+ CTL tumor immunosurveillance and regulation of tumor escape by CD4 T cells through an effect on quality of CTLS Matsui, J D Ahlers, A O Vortmeyer, et al.
Nature Medicine|October 1, 1996
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsD I Gabrilovich, H L Chen, K R Girgis, et al.
Chest|December 1, 1994
p53 immunostaining positivity is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer. A preliminary report of LCSG 871D P Carbone, T Mitsudomi, I Chiba, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2000
Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancerB Almand, J I Clark, E Nikitina, et al.
Human Gene Therapy|December 31, 1997
Overexpression of adenovirus-encoded transgenes from the cytomegalovirus immediate early promoter in irradiated tumor cellsD C Tang, R S Jennelle, Z Shi, et al.
Nature Immunology|March 23, 2001
NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathwayM Terabe, S Matsui, N Noben-Trauth, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Cancer Gene Therapy|July 1, 1996
Increased immunogenicity of tumors bearing mutant p53 and P1A epitopes after transduction of B7-1 via recombinant adenovirusC T Lee, I F Ciernik, S Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Clinical significance of defective dendritic cell differentiation in cancerB Almand, J R Resser, B Lindman, et al.
Immunity|June 23, 2001
Regulation of mast cell survival by IgEK Asai, J Kitaura, Y Kawakami, et al.
International Journal of Cancer|September 17, 1996
Structural and functional analysis of beta2 microglobulin abnormalities in human lung and breast cancerH L Chen, D Gabrilovich, A Virmani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
A model for CD8+ CTL tumor immunosurveillance and regulation of tumor escape by CD4 T cells through an effect on quality of CTLS Matsui, J D Ahlers, A O Vortmeyer, et al.
Nature Medicine|October 1, 1996
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsD I Gabrilovich, H L Chen, K R Girgis, et al.
Chest|December 1, 1994
p53 immunostaining positivity is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer. A preliminary report of LCSG 871D P Carbone, T Mitsudomi, I Chiba, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2000
Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancerB Almand, J I Clark, E Nikitina, et al.
Human Gene Therapy|December 31, 1997
Overexpression of adenovirus-encoded transgenes from the cytomegalovirus immediate early promoter in irradiated tumor cellsD C Tang, R S Jennelle, Z Shi, et al.
Nature Immunology|March 23, 2001
NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathwayM Terabe, S Matsui, N Noben-Trauth, et al.
Pageof 10